Exercise Adherence and Optimal Nutrition Post Rehabilitation Among People With Parkinson's Disease

NCT04945876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-06-25

No results posted yet for this study

Summary

A randomized, controlled trial to evaluate the effect of six months digital follow-up, after a stay at a rehabilitation center, on functional and nutritional status in people with Parkinson Disease.

Conditions

  • Parkinson Disease

Interventions

BEHAVIORAL

Digital follow-up

Participants will receive: One session of individual exercise and diet guidance focusing on goals and motivation. An activity tracker and instructions on how to use it both for motivation, daily activity tracking, logging of specific exercise and using the wristbands heart rate monitor to control intensity level during exercise. Monthly digital follow-up to provide support and address questions and goals regarding nutrition, daily energy expenditure and exercise. Opportunity to send sms with questions regarding nutrition and exercise. Participants who are malnourished, or at risk of malnutrition will be offered a total of two hours of additional individualized, digital guidance on nutrition as needed.

Sponsors & Collaborators

  • Unicare Fram

    collaborator UNKNOWN
  • Norwegian Parkinson's Association

    collaborator UNKNOWN
  • Lovisenberg Diaconal University College

    collaborator OTHER
  • Karolinska Institutet

    collaborator OTHER
  • Aalborg University Hospital

    collaborator OTHER
  • Fysiofondet

    collaborator OTHER
  • Oslo Metropolitan University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-30
Primary Completion
2023-06-23
Completion
2023-06-28

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04945876 on ClinicalTrials.gov